Retatrutide Agonist
Retatrutide Agonist
Retatrutide Agonist
Retatrutide Agonist
Retatrutide Agonist
Retatrutide Agonist
Retatrutide Agonist
Retatrutide Agonist
Retatrutide Agonist
Retatrutide Agonist

Retatrutide Agonist

Price 15.0 USD ($)/ Piece

MOQ : 100 Pieces

Retatrutide Agonist Specification

  • Indication
  • For improving glycemic control and weight management
  • Salt Composition
  • Retatrutide
  • Brand Name
  • As per manufacturer
  • Dosage Form
  • Injection
  • Packaging Type
  • Vial
  • Origin of Medicine
  • Synthetic
  • Pacakaging (Quantity Per Box)
  • 1 vial per box
  • Life Span
  • 24 months from manufacturing
  • Drug Type
  • Biologic Peptide
  • Ingredients
  • Retatrutide
  • Physical Form
  • Lyophilized Powder
  • Function
  • GLP-1/GIP/Glucagon Receptor Agonist
  • Recommended For
  • Type 2 Diabetes, Obesity Management
  • Dosage
  • As prescribed by physician
  • Dosage Guidelines
  • Administer subcutaneously as directed
  • Suitable For
  • Adults
  • Quantity
  • 5 mg/vial
  • Storage Instructions
  • Store at 2C - 8C, protect from light
  • Route of Administration
  • Subcutaneous
  • Contraindications
  • Not recommended in patients with hypersensitivity to components
  • Marketed By
  • Available under various trademarks
  • Molecular Weight
  • ~7371 Da
  • Side Effects
  • May include nausea, vomiting, decreased appetite
  • Appearance
  • White to off-white powder
  • Safety Information
  • For use under medical supervision only
  • Molecular Formula
  • C314H483N89O97S2
  • Purity
  • 98% (HPLC)
 
 

About Retatrutide Agonist

Small volumes of Retatrutide agonist vial may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

How Does Retatrutide Agonist Work?

Retatrutide serves as a GLP-1, GIP, and Glucagon receptor agonist. This mechanism enhances insulin secretion, suppresses glucagon release, and promotes satiety, contributing to better glycemic control and weight management. The unique combination of actions makes it particularly useful for adults dealing with type 2 diabetes and obesity.


Usage and Dosage Guidelines

Retatrutide Agonist is administered via subcutaneous injection, typically once per week or as prescribed by your physician. The exact dosage depends on individual patient needs and medical advice. Always follow your doctor's instructions, and never self-administer without guidance.


Storage and Handling Instructions

To maintain product stability, store Retatrutide at 2C-8C and protect it from light. Each vial contains 5 mg of lyophilized powder, intended for reconstitution and single use only. Proper storage ensures the medicine remains effective for up to 24 months from the manufacturing date.

FAQ's of Retatrutide Agonist:


Q: How should Retatrutide Agonist be administered?

A: Retatrutide Agonist is administered as a subcutaneous injection, typically by a healthcare professional. The dosage and frequency must be determined by your physician based on your health status and treatment goals.

Q: What are the key benefits of using Retatrutide Agonist?

A: This medication improves glycemic control and supports weight management, especially in adults with type 2 diabetes or obesity. Its triple receptor agonist action offers multifaceted metabolic benefits beyond traditional therapies.

Q: When are the effects of Retatrutide Agonist usually noticeable?

A: Individual response times may vary, but improvements in glycemic control and appetite reduction can often be observed within a few weeks after regular administration, under the supervision of your physician.

Q: Where should Retatrutide Agonist be stored?

A: Store the vials at 2C to 8C in a refrigerator and keep them protected from light. Do not freeze the product; improper storage may compromise efficacy and safety.

Q: What precautions should be taken before starting Retatrutide Agonist?

A: This medicine should only be used under medical supervision. It is contraindicated in patients with hypersensitivity to its components. Inform your physician of any allergies, medical conditions, or concurrent medications before starting treatment.

Q: What are common side effects of Retatrutide Agonist?

A: Some individuals may experience side effects such as nausea, vomiting, or decreased appetite. Report any unusual or severe symptoms to your healthcare provider promptly.

Q: Can Retatrutide Agonist be used for purposes other than diabetes and obesity management?

A: Retatrutide is recommended primarily for type 2 diabetes and weight management. Use for any other purposes should be strictly based on a healthcare provider's evaluation and guidance.

Tell us about your requirement
product

Price:

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
Mobile number

Email



Back to top